Hanna WM - Search Results

1

A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.

Burger AM, Gao Y, Amemiya Y, Kahn HJ, Kitching R, Yang Y, Sun P, Narod SA, Hanna WM, Seth AK. Burger AM, et al. Among authors: hanna wm. Cancer Res. 2005 Nov 15;65(22):10401-12. doi: 10.1158/0008-5472.CAN-05-2103. Cancer Res. 2005. PMID: 16288031

2

Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery.

Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA, McCready DR. Cil T, et al. Cancer. 2009 Dec 15;115(24):5780-7. doi: 10.1002/cncr.24638. Cancer. 2009. PMID: 19902459 Free article.

3

Prognostic factors affecting the natural history of node-negative breast cancer.

Trudeau ME, Pritchard KI, Chapman JA, Hanna WM, Kahn HJ, Murray D, Sawka CA, Mobbs BG, Andrulis I, McCready DR, Lickley HL. Trudeau ME, et al. Among authors: hanna wm. Breast Cancer Res Treat. 2005 Jan;89(1):35-45. doi: 10.1007/s10549-004-1368-y. Breast Cancer Res Treat. 2005. PMID: 15666195

4

Triple-negative breast cancer: clinical features and patterns of recurrence.

Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Dent R, et al. Among authors: hanna wm. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045. Clin Cancer Res. 2007. PMID: 17671126

5

Pattern of metastatic spread in triple-negative breast cancer.

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Dent R, et al. Among authors: hanna wm. Breast Cancer Res Treat. 2009 May;115(2):423-8. doi: 10.1007/s10549-008-0086-2. Epub 2008 Jun 10. Breast Cancer Res Treat. 2009. PMID: 18543098

6

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.

Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, Narod SA, Hanna WM. Nofech-Mozes S, et al. Among authors: hanna wm. Breast Cancer Res Treat. 2009 Nov;118(1):131-7. doi: 10.1007/s10549-008-0295-8. Epub 2009 Feb 3. Breast Cancer Res Treat. 2009. PMID: 19189211

7

Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Dent R, et al. Among authors: hanna wm. Cancer. 2009 Nov 1;115(21):4917-23. doi: 10.1002/cncr.24573. Cancer. 2009. PMID: 19691094 Free article.

8

RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.

Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, Marks A. Kahn HJ, et al. Breast Cancer Res Treat. 2000 Mar;60(2):143-51. doi: 10.1023/a:1006350913243. Breast Cancer Res Treat. 2000. PMID: 10845277

9

Tumour characteristics among women with very low-risk breast cancer.

Narod SA, Valentini A, Nofech-Mozes S, Sun P, Hanna W. Narod SA, et al. Breast Cancer Res Treat. 2012 Aug;134(3):1241-6. doi: 10.1007/s10549-012-2065-x. Epub 2012 May 1. Breast Cancer Res Treat. 2012. PMID: 22547106

10

Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event.

Hanna W, Nofech-Mozes S, Kahn HJ. Hanna W, et al. Breast J. 2007 Mar-Apr;13(2):122-9. doi: 10.1111/j.1524-4741.2007.00396.x. Breast J. 2007. PMID: 17319852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters